Structure | Chemical Name | CAS | MF |
|
Mutant IDH1 inhibitor
|
1429180-08-4
|
C25H34N6O3
|
|
6,6,7,7,8,8,8-Heptafluoro-5,5-bis(trifluoromethyl)-1,3-octadiene
|
1429188-77-1
|
C10H5F13
|
|
2,3-Dihydro-2-(5-methyl-2-thienyl)-3-phenyl-4(1H)-quinazolinone
|
1429192-00-6
|
C19H16N2OS
|
|
N,N-Bis(4-bromophenyl)-4-fluoroaniline
|
1429194-04-6
|
C18H12Br2FN
|
|
rac-cis-1-Deshydroxy Rasagiline
|
1429220-15-4
|
C12H13NO
|
|
rac-trans-1-Deshydroxy Rasagiline
|
1429220-16-5
|
C12H13NO
|
|
6-(4-ISOPROPYLSTYRYL)-2-METHYL-3(2H)-PYRIDAZINONE
|
1429221-97-5
|
C16H18N2O
|
|
(R)-Hexahydro-pyrrolo[1,2-a]pyrazin-6-one hydrochloride
|
1429238-55-0
|
C7H13ClN2O
|
|
1-(2,4-Dichlorophenyl)-N-1-piperidinyl-4-[[(1-pyrrolidinylsulfonyl)amino]methyl]-5-[5-[2-[4-(trifluoromethyl)phenyl]ethynyl]-2-thienyl]-1H-pyrazole-3-carboxamide
|
1429239-98-4
|
C33H31Cl2F3N6O3S2
|
|
(5-(2-ethylhexyl)thiophen-2-yl)trimethylstannane
|
1429306-71-7
|
C15H28SSn
|
|
Ethyl 1-(2-Morpholinopyridin-4-yl)-1H-pyrazole-4-carboxylate
|
1429309-21-6
|
C15H18N4O3
|
|
ethyl 4-aMino-5-Methyl-2,5-dihydrofuran-3-carboxylate
|
1429309-22-7
|
C8H13NO3
|
|
4-Oxo-4-(4-propylphenyl)butanoyl chloride
|
1429309-23-8
|
C13H15ClO2
|
|
(3-Ethynylpiperidin-1-yl)(phenyl)methanone
|
1429309-24-9
|
C14H15NO
|
|
(1-(2-Morpholinopyridin-4-yl)-1H-pyrazol-4-yl)Methanol
|
1429309-26-1
|
C13H16N4O2
|
|
3-BroMo-5,6-diMethylpyrazolo[1,5-a]pyriMidin-7(4H)-one
|
1429309-27-2
|
C8H8BrN3O
|
|
3-BroMo-8-Methoxy-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyriMidine
|
1429309-28-3
|
C10H10BrN3O
|
|
3-BroMo-6-ethyl-7-Methoxy-5-Methylpyrazolo[1,5-a]pyriMidine
|
1429309-29-4
|
C10H12BrN3O
|
|
(1-(2-(DiMethylaMino)pyridin-4-yl)-1H-pyrazol-4-yl)Methanol
|
1429309-30-7
|
C11H14N4O
|
|
3-BroMo-7-Methoxy-5,6-diMethylpyrazolo[1,5-a]pyriMidine
|
1429309-31-8
|
C9H10BrN3O
|
|
2-(4-broMo-5-nitro-1H-pyrazol-1-yl)ethanol
|
1429309-32-9
|
C5H6BrN3O3
|
|
1-(4-Bromophenylsulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
|
1429309-33-0
|
C13H7BrClN3O4S
|
|
3-BroMo-6,7-dihydro-4H-cyclopenta[d]pyrazolo[1,5-a]pyriMidin-8(5H)-one
|
1429309-35-2
|
C9H8BrN3O
|
|
3-BroMo-9-Methoxy-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline
|
1429309-36-3
|
C11H12BrN3O
|
|
5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxamide
|
1429309-37-4
|
C8H6BrN3O
|
|
(1-(4-((Tetrahydrofuran-3-yl)oxy)pyridin-2-yl)-1H-pyrazol-4-yl)Methanol
|
1429309-39-6
|
C13H15N3O3
|
|
3-BroMo-7-chloro-5,6-diMethylpyrazolo[1,5-a]pyriMidine
|
1429309-40-9
|
C8H7BrClN3
|
|
5-Chloro-4-nitro-1-propyl-1H-pyrazole
|
1429309-41-0
|
C6H8ClN3O2
|
|
3-BroMo-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-9(4H)-one
|
1429309-42-1
|
C10H10BrN3O
|
|
Ethyl 1-(5-Methylpyridin-2-yl)-1H-pyrazole-3-carboxylate
|
1429309-43-2
|
C12H13N3O2
|
|
7-Methyl-5,7-dihydrofuro[3,4-d]pyriMidine-2,4(1H,3H)-dione
|
1429309-44-3
|
C7H8N2O3
|
|
tert-butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate
|
1429309-49-8
|
C20H27N5O4
|
|
5-broMo-4-nitro-1-propyl-1H-pyrazole
|
1429309-51-2
|
C6H8BrN3O2
|
|
2,4-Dichloro-7-Methyl-5,7-dihydrofuro[3,4-d]pyriMidine
|
1429309-52-3
|
C7H6Cl2N2O
|
|
1-allyl-5-broMo-4-nitro-1H-pyrazole
|
1429309-53-4
|
C6H6BrN3O2
|
|
5-BroMo-4-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole
|
1429309-54-5
|
C8H10BrN3O3
|
|
Rivaroxaban Related Compound (R-4-(4-(5-(Aminomethyl)-2-Oxooxazolidin-3-yl)phenyl-Morpholin-3-One HCl)
|
1429311-47-6
|
C14H18ClN3O4
|
|
4-Bromo-3-fluorosalicylic acid, 3-Bromo-6-carboxy-2-fluorophenol
|
1429321-82-3
|
C7H4BrFO3
|
|
AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-
|
1429334-00-8
|
C16H19N3O5
|
|
Linezolid Impurity 23 HCl
|
1429334-07-5
|
C5H11Cl2NO2
|
|
1,4-di(pyridin-4-yl)naphthalene
|
1429342-63-1
|
C20H14N2
|
|
2,2,6,6-tetramethyltetrahydro-2H-pyran-4-carboxylic acid
|
1429421-99-7
|
C10H18O3
|
|
5-Chloro-2,4-difluorophenylacetonitrile
|
1429422-26-3
|
C8H4ClF2N
|
|
Benzene, 1-chloro-5-(chloromethyl)-2,4-difluoro-
|
1429422-43-4
|
C7H4Cl2F2
|
|
3,5-Di(3-carboxyphenyl)pyridine
|
1429436-06-5
|
C19H13NO4
|
|
5-chloro-1-ethyl-3-(hydroxymethyl)-6,7-bis((4-methoxybenzyl)oxy)quinolin-4(1H)-one
|
1429439-25-7
|
C28H28ClNO6
|
|
5-Chloro-1-cyclopropyl-1,4-dihydro-6,7-bis[(4-methoxyphenyl)methoxy]-4-oxo-3-quinolinecarboxylic acid
|
1429440-05-0
|
C29H26ClNO7
|
|
Daptomycin
|
1429504-48-2
|
C31H30N2O8
|
|
(S)-tert-butyl 1-(tetrahydrofuran-3-yl)hydrazinecarboxylate
|
1429510-48-4
|
C9H18N2O3
|
|
N-[3,5-bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-(dipentylamino)cyclohexyl]-Thiourea
|
1429516-79-9
|
C25H37F6N3S
|
|
4-Fluoro-3,5-dimethylcinnamic acid
|
1429551-15-4
|
C11H11FO2
|
|
DDR1-IN-2
|
1429617-90-2
|
C30H29F3N6O
|
|
PI4KIIIbeta-IN-9
|
1429624-84-9
|
C23H25N3O5S2
|
|
Doxofylline Impurity 6
|
1429636-72-5
|
C11H16N4O4
|
|
Doxofylline Impurity 1
|
1429636-74-7
|
C10H16N4O3
|
|
CZ415
|
1429639-50-8
|
C22H29N5O4S
|
|
tert-butyl N-allyl-N-[2-(methoxy(methyl)amino)-2-oxo-ethyl]carbamate
|
1429646-79-6
|
C12H22N2O4
|
|
HPOB
|
1429651-50-2
|
C17H18N2O4
|
|
9,10-bis((E)-2-(pyridin-3-yl)vinyl)anthracene
|
1429664-95-8
|
C28H20N2
|
|
3-chloroisoquinolin-5-yl-5-boronic acid
|
1429665-44-0
|
C9H7BClNO2
|
|
N2-[(phenylmethoxy)carbonyl]-N6-(1-thioxotetradecyl)-L-Lysine
|
1429749-38-1
|
C28H46N2O4S
|
|
Thiomyristoyl
|
1429749-41-6
|
C34H51N3O3S
|
|
6-Quinazolinol, 4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-, 6-acetate
|
1429757-64-1
|
C17H12Cl2FN3O3
|
|
4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-ol
|
1429757-65-2
|
C15H10Cl2FN3O2
|
|
Poziotinib(HM 781-36B)
|
1429757-68-5
|
C23H22Cl3FN4O3
|
|
4-Chloro-2,6-diMethylquinazoline
|
1429782-21-7
|
C10H9ClN2
|
|
FOR-MET-LEU-AMC
|
1429788-64-6
|
C22H29N3O5S
|
|
7-broMo-8-chloroquinoline
|
1429790-80-6
|
C9H5BrClN
|
|
(2-Methoxy-6-(trifluoroMethyl)pyridin-3-yl)boronic acid
|
1429874-11-2
|
C7H7BF3NO3
|
|
UNC2025
|
1429881-91-3
|
C28H40N6O
|
|
UNC-2371A
|
1429882-07-4
|
C29H40N6O
|
|
7-Bromo-2-chloro-5H-pyrrolo[3,2-d]pyrimidine
|
1429882-36-9
|
C6H3BrClN3
|
|
4-Isopropoxy-3,5-dimethyl-benzoic acid methyl ester
|
1429901-53-0
|
C13H18O3
|
|
6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-1-amine
|
1429901-83-6
|
C12H13FN2
|
|
3,5-Difluoro-4-methylbenzaldehyde
|
1429902-14-6
|
C8H6F2O
|
|
5-oxo-1-(3,4,5-trifluorophenyl)pyrrolidine-3-carboxylic acid
|
1429902-34-0
|
C11H8F3NO3
|
|
3-Ethoxy-5-(trifluoromethyl)benzenamine
|
1429903-76-3
|
C9H10F3NO
|
|
2-(2,5-Dimethoxyphenyl)-1-oxo-1,2-dihydroisoquinoline-4-carboxylic acid
|
1429903-79-6
|
C18H15NO5
|
|
2-(2-Methoxy-phenyl)-1-oxo-1,2-dihydro-isoquinoline-4-carboxylic acid
|
1429903-98-9
|
C17H13NO4
|
|
3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile
|
1429906-71-7
|
C20H30BN3O3Si
|
|
1-[2-[(2,4-diMethylphenyl)sulfinyl]phenyl]- Piperazine
|
1429908-35-9
|
C18H22N2OS
|
|
BENZYL (3,3-DIFLUORO-2-HYDROXYPROPYL)CARBAMATE
|
1429913-43-8
|
C11H13F2NO3
|
|
Propargyl-PEG5-CH2CO2H
|
1429934-37-1
|
C13H22O7
|
|
(-)-1,13-Bis[di(3,5-diMethylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (S,S,S)-(-)-Xyl-SKP
|
1429939-31-0
|
C52H54O2P2
|
|
(+)-1,13-Bis[di(4-Methylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene
|
1429939-32-1
|
C48H46O2P2
|
|
(+)-1,13-Bis[di(3,5-diMethylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Xyl-SKP
|
1429939-35-4
|
C52H54O2P2
|
|
4-METHOXYPHENYL 2-AZIDO-4,6-O-BENZYLIDENE-2-DEOXY-BETA-D-GLUCOPYRANOSIDE
|
1430068-18-0
|
C20H21N3O6
|
|
2,4-PyriMidinediaMine with linker
|
1430089-64-7
|
C19H24N8
|
|
7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one
|
1430092-39-9
|
C16H12F3NO3
|
|
1,2,4,5-tetra(pyridin-3-yl) benzene
|
1430117-49-9
|
C26H18N4
|
|
(2S,6S)-2-AMINO-2-(2-CHLOROPHENYL)-6-HYDROXYCYCLOHEXAN-1-ONE HCL
|
1430202-70-2
|
C12H15Cl2NO2
|
|
1A-116
|
1430208-73-3
|
C16H16F3N3
|
|
ML216
|
1430213-30-1
|
C15H9F4N5OS
|
|
PotassiuM N-boc-piperidinyl-4-trifluoroborate
|
1430219-71-8
|
C10H18BF3KNO2
|
|
PotassiuM 1-Boc-pyrrolidine-3-trifluoroborate
|
1430219-72-9
|
C9H16BF3KNO2
|
|
PotassiuM (1-(tert-butoxycarbonyl)azetidin-3-yl)trifluoroborate
|
1430219-73-0
|
C8H13BF3KNO2
|
|
PotassiuM trifluoro(oxetan-3-yl)borate
|
1430219-76-3
|
C3H4BF3KO
|
|
Alogliptin Related Compound 24
|
1430222-06-2
|
C14H12ClN3O2
|
|
Alogliptin Related Compound 18
|
1430222-09-5
|
C26H23N5O4
|
|
2,5-Difluoro-4-(4-methylpiperazin-1-yl)benzoic acid
|
1430223-87-2
|
C12H14F2N2O2
|